Navigation Links
Jazz Pharmaceuticals Files Form S-3 Registration Statements
Date:6/11/2008

y's election to draw down funds pursuant to the committed equity financing facility entered into with Kingsbridge Capital Limited in May 2008, as well as the common stock issuable upon exercise of an outstanding warrant issued to Kingsbridge in connection with the transaction. If and when declared effective by the SEC, the resale registration statements will allow the selling securityholders named therein to publicly resell shares of the company's common stock issuable pursuant to the committed equity financing facility and upon the exercise of the above-referenced warrants, as applicable. Written prospectuses, when available, may be obtained from Jazz Pharmaceuticals at 3180 Porter Drive, Palo Alto, California 94304, Attention: Investor Relations.

The registration statements relating to these securities have been filed with the SEC but have not yet become effective. These securities may not be sold, nor may offers to buy be accepted prior to the time the applicable registration statement becomes effective. This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. For further information see http://www.JazzPharmaceuticals.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements, including, but not limited to, statements related to the offering of securities by Jazz Pharmaceuticals and the issuance of additional debt under an ex
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Quark Pharmaceuticals to Participate in 9th Annual Beyond Genome Conference
2. Merrimack Pharmaceuticals Raises $60 Million in Private Financing
3. The Leukemia & Lymphoma Society and Provid Pharmaceuticals Announce Collaboration on Treatment for Acute Myelogenous Leukemia
4. Diffusion Pharmaceuticals Announces Addition of Mark T. Giles to its Board of Directors
5. Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals
6. Amira Pharmaceuticals Hires Industry Veteran for CFO Position
7. Memory Pharmaceuticals Receives Anticipated NASDAQ Staff Determination Letter
8. Raptor Pharmaceuticals Corp. Receives FDA Orphan Drug Designation for Cysteamine in Huntingtons Disease
9. Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference
10. Amylin Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference
11. LabCorp(R) and Vanda Pharmaceuticals Collaborate to Offer Genetic Tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire/ - iCo Therapeutics ... today reported financial results for the six months ... are expressed in Canadian dollars and presented under ... Quarter 2014 Highlights , Announced top-line ... (VA) primary endpoint for subjects enrolled in the ...
(Date:8/29/2014)... Due to a misstatement posted by the ... Cell Technology Center, LLC ( ASCTC ) was reported as ... that might benefit ALS patients. Because of ASCTC's exclusive ... technologies and therapeutic applications, FRC listed ASCTC as one of ... who wish not to support research that requires the death ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 SPIE Fellow ... Physics and Optical Science and Director of the Center ... North Carolina at Charlotte, and co-founder and Chairman of ... serve as the 2015 Vice President of SPIE, the ... President Philip Stahl announced recent election results at the ...
(Date:8/28/2014)... “This kit has an improved extraction efficiency and provides users ... said Mark Tess, PhD, Mycotoxin Product Manager for Charm Sciences. ... USDA-GIPSA inspection agencies that have a need to detect aflatoxin ... a matter of minutes with nothing but our equipment and ... grain before accepting it, but they no longer have to ...
Breaking Biology Technology:iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3Glenn Boreman, UNC Professor and Plasmonics Co-Founder, Elected to SPIE Presidential Chain 2
... ... Delay, LEXINGTON, Mass., ... Glenn L. Cooper,MD, its chairman and chief executive officer is postponing his,previously-announced ... of the recent delay in the approval of NEBIDO(R)., Dr. Cooper ...
... Raymond J. De,Hont, Chairman and Chief Executive Officer ... Fybroc business unit has received,an order for approximately $500,000 ... second and third quarters of the Company,s current fiscal ... order Fybroc has received this year from the,Eastern European ...
... Cell Therapeutics, Inc.,(Nasdaq and MTA: CTIC) today announced that ... million, newly issued 15% Convertible,Senior Notes due 2011, with ... warrant to purchase approximately 14.6 million shares of common ... This transaction constitutes a partial exercise of a previously ...
Cached Biology Technology:Indevus Announces Management Changes 2Indevus Announces Management Changes 3Indevus Announces Management Changes 4Met-Pro Corporation's Fybroc Business Unit Receives Equipment Order Totaling Approximately $500,000 2Met-Pro Corporation's Fybroc Business Unit Receives Equipment Order Totaling Approximately $500,000 3Cell Therapeutics, Inc. Announces Issuance of 2011 Convertible Senior Notes and Common Stock Warrants to a Single Institutional Investor 2
(Date:8/31/2014)... and accurate tool to diagnose tuberculosis in children, ... test (TAM-TB assay) is the first reliable immunodiagnostic ... test features excellent specificity, a similar sensitivity as ... blood test. The promising findings are a major ... particularly in tuberculosis-endemic regions. , The study has ...
(Date:8/31/2014)... the greatest challenges in modern medicine is developing drugs ... minimal toxicity and side-effects to the patient. Such properties ... drug molecule. Ideally, the drug should have a shape ... that it binds it with high specificity. Publishing in ... synthetic amino acid that can impact the 3D structure ...
(Date:8/31/2014)... study of satellite data from the last 19 years reveals ... around the coast of Antarctica to rise by 2cm more ... University of Southampton detected the rapid rise in sea-level by ... a million square kilometres. , The melting of ... shelves has contributed an excess of around 350 gigatonnes of ...
Breaking Biology News(10 mins):New tuberculosis blood test in children is reliable and highly specific 2A new synthetic amino acid for an emerging class of drugs 2A new synthetic amino acid for an emerging class of drugs 3
... June 28, 2013 -- A single systemic dose of ... in a preclinical animal model of kidney transplantation, according ... Medicine. Their findings, now available in the online version ... lay the foundation for eventual human trials of the ...
... the ,parrot dinosaur, is known from more than 1000 specimens from ... of east Asia. As part of his PhD thesis at ... the Institute for Vertebrate Paleontology in Beijing, carried out the intricate ... said: "Some of the bones from baby Psittacosaurus were ...
... multitude of microbes colonizing and thriving on flecks of ... flotilla of microbial communities that they have dubbed the ... Environmental Science & Technology , the scientists say ... ocean and raises a host of questions: How will ...
Cached Biology News:Dendritic cell therapy improves kidney transplant survival, Pitt team says 2Exploring dinosaur growth 2Scientists discover thriving colonies of microbes in ocean 'plastisphere' 2
... XIII in both reduced and non-reduced forms. It ... or human Factor XII. Factor XIII is a ... two subunits. Factor XIII-A is the catalytic subunit ... XIII is present in plasma as an Alpha2Beta2 ...
Anti-CaM kinase II recognizes the enzymes a subunit (6) and reacts with tissue from all mammalian species tested, as well as with chicken and frog tissues....
Ca2+ Channel Ca gamma 2 Purified Anti-Mouse, Anti-Rat, Anti-Human clone Polyclonal, Isotype Rabbit Ig, 50 µl Consult technical datasheet for details....
Goat polyclonal to Centaurin alpha 2**...
Biology Products: